Completed OBSERVATIONAL NCT05154084

RESECT: Improving Quality in TURBT Surgery. (RESECT)

Transurethral REsection and Single Instillation Intra-vesical Chemotherapy Evaluation in Bladder Cancer Treatment (RESECT) Improving Quality in TURBT Surgery

Sponsor: Action Bladder Cancer UK

Conditions Bladder Cancer

Interventions Performance feedback and education

Updated 5 times since 2022 Last updated: Nov 12, 2023 Started: Apr 19, 2021 Primary completion: Jul 31, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Bladder Cancer and is currently completed. Action Bladder Cancer UK leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jun 2022 — Dec 2023 [monthly]

Recruiting
Jan 2022 — Jun 2022 [monthly]

Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Action Bladder Cancer UK
British Journal of Urology International
British Urology Researchers in Surgical Training
KARL STORZ Endoscopy-America, Inc.
Photocure
Rosetrees Trust
The Urology Foundation, United Kingdom
University College, London
University of Aberdeen

Data source: British Urology Researchers in Surgical Training

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom